Stable isotope techniques in early drug development: An economic evaluation

Journal of Clinical Pharmacology

Volumn 38, Issue 3, 1998, Pages 213-220

  Browne, Thomas R ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ISOTOPE;

ANALYTIC METHOD; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG LABELING; DRUG MONITORING; DRUG STABILITY; ECONOMIC ASPECT; HUMAN; TECHNIQUE;

EID: 0031894162     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04418.x     Document Type: Article

References (33)

1. Browne TR: Stable isotopes in clinical investigations: advantage and disadvantages. Clin Pharmacokinet 1990;18:423-433.
2. Browne TR: Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods. Epilepsy Res 1993;(supplement 10):31-44.
3. Browne TR: Stable Isotopes in Pharmaceutical Research. Amsterdam: Elsevier, 1997.
4. Wolen RL, Garland WA: A review of the methodology for application of stable isotope technology to pharmacokinetic studies, 1973-1988. In, Baille TA, Jones JR (eds.): Synthesis and Applications of Isotopically Labeled Compounds 1988. Amsterdam: Elsevier, 1989;147-156.
5. Abramson FP: Chemical reaction interface mass spectrometry. Mass Spectrom Rev 1995;13:341-357.
6. 14C with stable isotopes in drug metabolism studies. Drug Metabol Dispos 1996;24:697-701.
7. 15N) and continuous flow - isotope ratio mass spectrometry as an alternative to radioactive labeling methods. J Clin Pharmacol 1993;33:246-252.
8. Browne TR, Szabo GK, Ajami A: Performance of human mass balance/metabolite identification studies with stable isotopes and isotope ratio mass spectrometry. In, Allen J, Voges E (eds.): Synthesis and Applications of Isotopically Labeled Compounds 1994. Chichester: Wiley, 1995;435-441.
9. 15N) drug in whole urine using continuous flow-isotope ratio mass spectrometry. In, Allen J, Voges R (eds.): Synthesis and Applications of Isotopically Labeled Compounds 1994. Chichester: Wiley, 1995;443-448.
10. Browne TR, Szabo GK, Ajami A: Mass spectrometry: isotope ratio mass spectrometry. In, Browne TR (ed.): Stable Isotopes in Pharmaceutical Research. Amsterdam: Elsevier, 1997;119-126.
11. Browne TR, Szabo GK, Ajami A: Mass balance. In, Browne TR (ed.): Stable Isotopes in Pharmaceutical Research. Amsterdam, Elsevier, 1997;219-232.
12. Browne TR, Szabo, GK, Ajami A, Browne DG: Performance of human mass balance studies with stable isotope labeled drug and continuous flow-isotope ratio mass spectrometry: a progress report. J Clin Pharmacol (in press).
13. Goldthwaite CA, Hsich FY, Womble SW, Nobes BJ, Blair IA, Klunk LJ, Mayol RF: Liquid chromatography/chemical reaction interface mass spectrometry as an alternative to radio isotopes for quantitative drug metabolism studies. Anal Chem 1996;68:2996-3001.
14. Teffera Y, Kaslerz JJ, Abramson FP: Continuous-flow isotope ratio mass spectrometry using chemical reaction interface with either gas or liquid chromatography introduction. Anal Chem 1996;68:1888-1894.
15. Browne TR: Biotransformation and excretion: pharmacokinetic studies. In, Browne TR (ed.): Stable Isotopes in Pharmaceutical Research. Amsterdam: Elsevier, 1997;297-314.
16. Browne TR: Drug interactions. In, Browne TR (ed.): Stable Isotopes in Pharmaceutical Research. Amsterdam, Elsevier: 1997;337-346.
17. Browne TR, Evans JE, Szabo GK, Evans BA, Greenblatt DJ, Schumacher GE: Studies with stable isotopes. I. Changes in phenytoin pharmacokinetics and biotransformation during monotherapy. J Clin Pharmacol 1985;25:43-50.
18. Browne TR, Evans JE, Szabo GK, Evans BA, Schumacher GE: Studies with stable isotopes. II. Phenobarbital pharmacokinetics during monotherapy. J Clin Pharmacol 1985;25:51-60.
19. Browne TR, Greenblatt DJ, Harmatz JS, Szabo GK, Evans JE, Evans BA, Schumacher GE: Studies with stable isotopes. III. Pharmacokinetics of tracer doses of drug. J Clin Pharmacol 1985;25:59-63.
20. Wolen RL: Absorption: application of stable isotopes to studies of drug bioavailability and bioequivalence. J Clin Pharmacol 1986;26:419-424.
21. Powell ML: Absorption and bioequivalence. In. Browne TR (ed.): Stable Isotopes in Pharmaceutical Research, Amsterdam: Elsevier, 1997;243-260.
22. Browne TR, Greenblatt DJ, Schumacher GE, Szabo GK, Evans JE, Evans BA, et al: Comparison of methods for determination of pharmacokinetic drug interactions and proposals for new methods. In, Pitlick WH (ed.): Antiepileptic Drug Interactions. New York: Demos, 1989;3-25.
23. Browne TR, Szabo GK, Evans JE, Evans BA, Greenblatt DJ, Mikati MA: Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics. Neurology 1988; 38:639-642.
24. Browne TR, Szabo GK, Evans JE, Evans BA, Greenblatt DJ, Mikati MA: Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance. Neurology 1988;38:1146-1150.
25. Szabo GK, Pylilo RJ, Browne TR: Simultaneous separation and determination (in serum) of phenytoin and carbamazepine and their deuterated analogues by HPLC/UV for tracer studies. J Chromatogr 1990;535:271-277.
26. Szabo GK, Browne TR: Alternatives to mass spectrometry for quantitating stable isotopes: high performance liquid chromatography with conventional ultraviolet detection. In, Browne TR (ed.): Stable Isotopes in Pharmaceutical Research. Amsterdam: Elsevier, 1997;127-140.
27. Browne TR, Szabo GK, Josephs E, Kres J, Dingra U: Study of interaction with phenytoin using a stable isotope tracer methods not requiring mass spectrometry (abstract). Neurology 1997; 48:A111.
28. Browne TR, Szabo GK, Davoudi H, Josephs BS: Determination of pharmacokinetic drug interactions with carbamazepine and phenytoin using stable isotope labeling and simple high performance liquid chromatography/ultraviolet technique. Neurology 1994;44:2410-2411.
29. Browne TR: Isotope effect: consequences for pharmaceutical studies. In, Browne TR (ed.): Stable Isotope in Pharmaceutical Research. Amsterdam: Elsevier, 1997;13-18.
30. Bjorge SM: Identification and characterization of drug metabolites using stable isotope techniques. In. Browne TR (ed.): Stable Isotopes in Pharmaceutical Research. Amsterdam: Elsevier, 1997;233-242.
31. Perchalski RJ, Yost RA, Lee MS: Biotransformation and excretion: drug metabolite identification: stable isotope methods. J Clin Pharmacol 1986;26:435-442.
32. VandenHeuvel WJA: Biotransformation and excretion: drug metabolite identification, stable isotope methods. J Clin Pharmacol 1986;26:427-434.
33. VandenHeuvel WJA: Use of stable isotopes in elucidation of drug biotransformation processes. Xenobiotica 1987;17:397-412.